A Randomized Phase II Trial of Single-Agent Gemcitabine, Vinorelbine, or Docetaxel in Patients with Advanced Non-small Cell Lung Cancer Who Have Poor Performance Status and/or Are Elderly

Swan Swan Leong; Chee Keong Toh; Wan Teck Lim; Xu Lin; Say Beng Tan; Donald Poon; Miah Hiang Tay; Kian Fong Foo; Juliana Ho; Eng Huat Tan

doi:10.1097/jto.0b013e318031d06f

A Randomized Phase II Trial of Single-Agent Gemcitabine, Vinorelbine, or Docetaxel in Patients with Advanced Non-small Cell Lung Cancer Who Have Poor Performance Status and/or Are Elderly

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318031d06f ◽

2007 ◽

Vol 2 (3) ◽

pp. 230-236 ◽

Cited By ~ 34

Author(s):

Swan Swan Leong ◽

Chee Keong Toh ◽

Wan Teck Lim ◽

Xu Lin ◽

Say Beng Tan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

A Randomized Phase II Trial of Two Schedules of Docetaxel in Elderly or Poor Performance Status Patients with Advanced Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000263713.38826.8e ◽

2007 ◽

Vol 2 (4) ◽

pp. 306-311 ◽

Cited By ~ 34

Author(s):

Rogerio Lilenbaum ◽

Mark Rubin ◽

Joyce Samuel ◽

Laszlo Boros ◽

Tarek Chidiac ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

O7 An exploratory analysis of the impact of age, performance status, and comorbidity on clinical outcomes in a randomized phase II trial of single agent gemcitabine, vinorelbine or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly

Critical Reviews in Oncology/Hematology ◽

10.1016/s1040-8428(13)70064-7 ◽

2006 ◽

Vol 60 ◽

pp. S20-S21

Author(s):

J. Ngeow ◽

D. Poon ◽

S.S. Leong ◽

F. Gao ◽

C.K. Toh ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

The Impact

Download Full-text

Phase II trial of single agent oral vinorelbine in elderly (≥70 years) patients with advanced non small cell lung cancer and poor performance status

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19085 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19085-19085

Author(s):

D. Amoroso ◽

A. Camerini ◽

O. Siclari ◽

G. Tartarelli ◽

C. Puccetti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Oral Vinorelbine

Download Full-text

Trial of poor performance status patients (ToPPS): A randomized phase II trial of pemetrexed versus pemetrexed/bevacizumab versus pemetrexed/carboplatin/bevacizumab in patients with stage IIIb/IV non-small cell lung cancer and ECOG performance status 2.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps287 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS287-TPS287

Author(s):

D. R. Spigel ◽

R. Lilenbaum ◽

J. D. Hainsworth

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Ecog Performance Status ◽

Randomized Phase Ii

Download Full-text

Phase II trial of single-agent oral vinorelbine in elderly (≥70 years) patients with advanced non-small-cell lung cancer and poor performance status

Annals of Oncology ◽

10.1093/annonc/mdp525 ◽

2010 ◽

Vol 21 (6) ◽

pp. 1290-1295 ◽

Cited By ~ 11

Author(s):

A. Camerini ◽

C. Valsuani ◽

F. Mazzoni ◽

O. Siclari ◽

C. Puccetti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Oral Vinorelbine

Download Full-text

Oral Vinorelbine as single agent in the treatment of poor Performance Status (pPS) metastatic Non Small Cell Lung Cancer (NSCLC): a single institution experience

Annals of Oncology ◽

10.1093/annonc/mdv343.51 ◽

2015 ◽

Vol 26 ◽

pp. vi89

Author(s):

G.P. Spinelli ◽

V. Stati ◽

A. Papa ◽

L. Rossi ◽

M. Minozzi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Single Institution ◽

Oral Vinorelbine

Download Full-text

Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small cell lung cancer

Seminars in Oncology ◽

10.1016/s0093-7754(01)90221-0 ◽

2001 ◽

Vol 28 ◽

pp. 21-25 ◽

Cited By ~ 16

Author(s):

J HAINSWORTH

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Weekly Docetaxel

Download Full-text

Single-Agent Gefitinib in Patients with Untreated Advanced Non–Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial

Clinical Lung Cancer ◽

10.3816/clc.2005.n.028 ◽

2005 ◽

Vol 7 (2) ◽

pp. 127-132 ◽

Cited By ~ 24

Author(s):

David R. Spigel ◽

John D. Hainsworth ◽

Emily R. Burkett ◽

Howard A. Burris ◽

Denise A. Yardley ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Research Network ◽

Poor Performance Status ◽

Small Cell Lung ◽

Cancer Research Network

Download Full-text

P2-316: Phase II trial of pemetrexed and gemcitabine as first-line chemotherapy for elderly and/or poor performance status patients with stage iiib/iv non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284024.75029.ab ◽

2007 ◽

Vol 2 (8) ◽

pp. S699

Author(s):

Lee S. Schwartzberg ◽

Johnetta Blakely ◽

Mark Keaton ◽

Fred Schnell ◽

David Henry ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

First Line ◽

Line Chemotherapy

Download Full-text

Single agent gefitinib in poor performance status patients with previously untreated advanced non-small cell lung cancer: A Minnie Pearl Cancer Research Network phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7086 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7086-7086 ◽

Cited By ~ 3

Author(s):

N. R. Dickson ◽

J. D. Hainsworth ◽

D. R. Spigel ◽

H. A. Burris ◽

D. A. Yardley ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Single Agent ◽

Poor Performance ◽

Small Cell ◽

Research Network ◽

Poor Performance Status ◽

Small Cell Lung ◽

Cancer Research Network

Download Full-text